When seconds count: Interventional radiology treatment for pulmonary embolism saves lives

November 11, 2009

Catheter-directed therapy or catheter-directed thrombolysis -- an interventional radiology treatment that uses targeted image-guided drug delivery with specially designed catheters to dissolve dangerous blood clots in the lungs -- saves lives and should be considered a first-line treatment option for massive pulmonary embolism, note researchers in the November Journal of Vascular and Interventional Radiology.

"Modern catheter-directed therapy for acute pulmonary embolism saves lives, and we need to raise awareness about its safety and effectiveness not only among the general public but also within the medical community. It's a matter of life and death," said William Kuo, M.D., an interventional radiologist who is assistant professor and fellowship director of vascular and interventional radiology in the Department of Radiology at Stanford University Medical Center in Stanford, Calif. "In our study, we conclude that modern catheter-directed therapy is a relatively safe and effective treatment for acute massive pulmonary embolism and should be considered as a first-line treatment option," he added.

Pulmonary embolism occurs when one or more arteries in the lungs become blocked from that break free and travel there. These clots most often begin as (DVT) or blood clots within the deep leg veins. When the clots break free, circulate and become trapped in the lungs, they can block the oxygen supply, cause and result in death. About 600,000 cases of acute pulmonary embolism are diagnosed each year in the United States, and an estimated 300,000 patients die, noted Kuo. "If initiated early, minimally invasive catheter-directed therapy could save many of those lives," added the lead author of the study, "Catheter-directed Therapy for the Treatment of Massive Pulmonary Embolism: Systematic Review and Meta-analysis of Modern Techniques."

During the treatment, an interventional radiologist inserts specially designed catheters (thin plastic tubes) through a tiny incision into one's blood vessels and guides the catheters using real-time imaging without traditional open surgery. This allows an interventional radiologist to deliver a clot-busting medicine directly into the clot. The catheters may also be used to mechanically break up clots and suction them away. This treatment offers less pain and less recovery time than traditional open surgery, said Kuo.

Stanford University researchers conducted a meta-analysis of the treatment on 594 patients in 18 countries who were treated between 1990 and 2008. The treatment was lifesaving in 86.5 percent of the cases studied and had only a 2.4 percent chance of major complications. Researchers found that not only was the treatment effective, but it also appeared much safer than the historical complication rates reported from injecting high-dose clot-busting medicine systemically or directly into the blood stream where the drug can circulate throughout the body and cause major bleeding in up to 20 percent of patients.

Kuo began this study three years ago after he was asked to assist with a 62-year-old woman who had collapsed at home and was rushed to the emergency room with massive blood clots in her lungs. The patient had been given a large-dose intravenous infusion of clot-busing medicine, a treatment called systemic thrombolysis, but that had failed.

While Kuo was initially consulted to place a special filter to prevent more clots from traveling from the legs to the lungs, he knew it would do little to save her. "I could see that she was quickly dying and there was no time to waste. I remember telling the staff, 'We can do more than just insert a filter. We can go after these clots using specially designed catheters,'" said Kuo. After obtaining consent from the family, Kuo made a tiny incision into the patient's neck and inserted a catheter into the vein. He then used X-ray images (fluoroscopy) to guide the catheter, navigating through the heart and finally reaching the blood clots within the lungs. He injected a clot-busting drug directly into the clots and then used the catheter to mechanically break up the clots before suctioning them out. "The results were immediate, and the treatment saved her life," said Kuo. "That experience inspired me to initiate further studies and to raise awareness of this emerging life-saving procedure," he added.

According to Kuo, the study addressed the use of catheter-directed therapy for treating the most severe or life-threatening form of pulmonary embolism known as "massive" pulmonary embolism. Additional studies are needed to see if the treatment should be initiated in those patients with less severe or "sub-massive" pulmonary embolism, he added. To answer these questions and to analyze further treatment outcomes, Kuo's team is initiating the multicenter PERFECT (Pulmonary Embolism Response to Fragmentation, Embolectomy and Catheter Thrombolysis) registry. In the meantime, the Stanford researchers advocate the use of catheter-directed therapy for massive pulmonary embolism "as both an early and alternative treatment option at centers with the appropriate expertise," said Kuo.

More information: "Catheter-directed Therapy for the Treatment of Massive Pulmonary Embolism: Systematic Review and Meta-analysis of Modern Techniques" is published in the November Journal of Vascular and Interventional Radiology.

Source: Society of Interventional Radiology (news : web)

Related Stories

Recommended for you

Artificial beta cells

December 8, 2016

Researchers led by ETH Professor Martin Fussenegger at the Department of Biosystems Science and Engineering (D-BSSE) in Basel have produced artificial beta cells using a straightforward engineering approach.

Key regulator of bone development identified

December 8, 2016

Loss of a key protein leads to defects in skeletal development including reduced bone density and a shortening of the fingers and toes—a condition known as brachydactyly. The discovery was made by researchers at Penn State ...

Researchers question lifelong immunity to toxoplasmosis

December 8, 2016

Medical students are taught that once infected with Toxoplasma gondii—the "cat parasite"—then you're protected from reinfection for the rest of your life. This dogma should be questioned, argue researchers in an Opinion ...

TET proteins drive early neurogenesis

December 7, 2016

The fate of stem cells is determined by series of choices that sequentially narrow their available options until stem cells' offspring have found their station and purpose in the body. Their decisions are guided in part by ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.